This third edition of the Nano World Cancer Day was held in twelve different countries across Europe. It resulted in a positive and growing interest!

  • 70 different great speakers involved, please visit the page Fellow Speakers for more information
  • More than 400 people attended the event, including 70 journalists
  • More than 60 articles and several television reportages 


Organized by BioNanoNet in close collaboration with three Austrian ministries and the Austrian key-experts in oncology, the event was held at Vienna, at Bundesministerium für Wissenschaft, Forschung und Wirtschaft.

It was a press-talk of one hour included a Q&A-session with national press.

Read more


  • Dr. Stefan Hanslik, Federal Minister of Science, Research and Economy

  • Alexander Pogány, Ministry for Transport, Innovation and Technology 

  • Dr. Aleksander Zilberszac, Federal Minister of Health (Bmg)

  • Andreas Falk, MSc, CEO of Bionanonet

  • Prof. DI Dr. Robert Mader, Medical University of Vienna

  • Prof. DI Dr. Hannes Stockinger, Medical University of Vienna



The attendees were media, researchers, clinicians, Federal Ministries and the Association of the Austrian Chemical Industry. One key question arose after the speaker presentations and focus the attention: “What are the future opportunities to support Austrian translational nanomedical research and beyond and how to pave the way from research to market (start-ups) in this challenging field?”

For more information about the speakers please find the Press Kit (in German)


A video was released on the Austrian TV Chanel W24 here

An article was issued by FCIO Chemische Industrie paper here


Organized by Dechema under the aegis of the German NanoBioMedicine Platform, the event took place at Frankfurt.

It was a press conference opened to journalists and public.

Read more


  • Dr. Klaus-Michaël Weltring, Chairman of the German NanoBioMedicine Platform, Bioanalytikzentrum Münster
  • Prof. Dr. med Christoff von Kalle, Oncologist, Member of the Board Director of Heidelberg Center for Personalized Oncology, Heidelberg
  • Dr. Andrea Hanefeld, Director, Head Search & Evaluation Pharmaceutical & Early Development Technologies Biopharma | External Innovation, Merck KGaA, Darmstadt
  • PD Dr. Peter van Hoogevest, Head Development and Scientific Department, Lipoid GmbH, Ludwigshafen
  • Mr. Nicolas Gouze, ETPN representative, VDI/VDE Innovation + Technik GmbH, Berlin 


The event was a success with very interesting talks and discussions afterward between speakers and audience.

For more information and access to video and press material of the event please visit Dechema’s website


Organized by the General Secretariat for Research and Technology and theUniversity of Athens, under the auspices of the Ministry of Health, in attendance of the viceminister responsible for research and technology Prof Fotakis. The eventtook place in Athens.

The event was a press conference opened to journalists but also tostudents, researchers, professors, clinicians and Greek Ministry of Health administration. 

Read more


  • M. Gazouli, University of Athens Medical School
    Presentation of the European Technology Platform on Nanomedicine (ETPN)
  • E. P. Efstathopoulos, NKUA
    Presentation of the Greek Organization Nanotechnology for Health
  • N. Pippa, NKUA
    Smart nanoplatforms for anticancer drug administration. Where we stand today?
  • P. Bouziotis, N.C.S.R. “Demokritos”
    Radiolabeled nanoparticles as agents for dual imaging SPECT/MRI and PET/MRI applications
  • M. Gazouli, University of Athens Medical School
    Nanotechnology based isolation and molecular characterization of circulating tumor cells
  • H Iatrou, NKUA
    Smart polymeric hydrogels for Gemcitabine administration for pancreatic cancer therapy
  • G. Loudos, Technological Educational Institute of Athens
    The role of biomedical mechanics based on drug delivery nanoparticles (Bioimaging, ablation etc)
  • D. Tsoukalas, National Technical University of Athens
    The perspectives of using nanoparticle assemblies as a cancer sensor device
  • C. Demetzos, NKUA
    Nanosimilars vs Biosimilars. Law and ethic regulations


The Greece Nano World Cancer Day was successful with 150-160 people with the vice minister responsible for research and technology Prof Fotakis, the Dean of the National And Kapodistrian University of Athens prof Dimopoulos. Moreover well know journalists from,,,, etc. attended the event, and Dyomagazine issued a dedicated newsletter.

Greece Program (PDF 736k)


Organized by the Trinity College of Dublin together with the School of Medicine of Dublin, under the aegis of the Head of Clinical Medicine, the event took place in Dublin.
The event was a press conference opened to journalists and to students

Read more


  • Dr. Adriele PRINA-MELLO, LBCAM director, Nanomedicine Group, ETPNmember – Welcome, Opening and General introduction to nanomedicine

  • Prof. Jacintha O’SULLIVAN, Associate Professor, Department of Surgery and Innovator – Overview on Translational Oncology research

  • Dr. Dania MOVIA, Research Fellow, Department of Clinical Medicine – Latest development in nanomedicine targeted therapies

  • Dr. Roisin BYRNE, Research Fellow, Department of Surgery – Oesophageal and rectal adenocarcinoma: importance of neoadjuvant radiosensitivity

  • Prof. Joanne LYSAGHT, Associate Professor, Department of Surgery – Introduction to the Taught Master in Translational Oncology – Open forum discussion


Organized by the University of Milano-Bicocca and the National Institute of Tumor-Foundation IRCC together with the participation of the Fondation Don Carlo Gnocchi ONLUS, the event took place at University of Milano-Bicocca.

The event was a press conferenceopened to journalists, researchers and clinicians. The event was well coveredby the media. Afterwards close to 40 articles were issued.

Read more


  • Cristina Messa, Rector of University of Milano-Bicocca

  • Furio Gramatica, Fondation don Gnocchi and ETPN (European Technology Platform on Nanomedicine) representative

  • Nadia Zaffaroni, National Institute of Tumor-Foundation, IRCC

  • Federico Caligaris Cappio, Italian Association on Cancer Research,AIRC

  • Emilia De Biasi, President of the Health commission at the Italian Senato

  • Federico Pantellini, Medical Affairs Director in Oncology, Celgene

Moderator Francesco Nicotra, University of Milano-Bicocca


The Italian Press Event was a great success. More than 10 journalists attended the event and 3 press articles were issued on national newspapers and more than 30 articles are now available on internet.

The event was also broadcast and the video is now available online.

A video summarizing the event was made by the University Milano-Bicocca’s press Office and is available here.


Organized by NanoNextNLand the Technology Foundation STW, the event took place at Utrecht
The press conference was opened to journalists and also scientists, engineers, policymakers and patient representatives. One article was issued afterward on several regional and national newspapers.

Read more


  • Chair: Anja van de Stolpe, hDMT
  • Bob Pinedo, Medical Oncologist
    Nanomedicine and cancer
  • Anja van de Stolpe, hDMT
    Cancer on a chip
  • Twan Lammers, Experimental Molecular Imaging, RTWH Aachen Nanoparticles in diagnostics and tumor-directed medicine transport
  • Roel Deckers, Imaging Science Institute, UMC Utrecht
    Image guided treatment of breastcancer
  • Cees van Rijn, Aquamarijn Micro Filtration BV
    A nano-trap for circulating tumor cells
  • Robert Geertsma, RIVM & ETPN member
    Safe innovation approach for nanomedicine in oncology


The attendees enjoyed six clear, concise and interesting lectures aboutthe application of nanomedicine in the prevention and treatment of cancer byleading scientists in the Netherlands.

Please find further information about the event : a summary and a general report.


Articles were issued in several press regional papers as Leidsch dagbladIJmuiderCournatGooi&EemlanderNoordHollandsDagblad and in 3 national papers Ethic School, Gezondheiddichtbij and National journal ScienceGuide.


Organized by the International Iberian Nanotechnology Laboratory  with the collaboration of the Galician Innovation Agency, the Commission of Coordination and Development of the North, and Health Cluster Portugal, the event took place at the International Iberian Nanotechnology Laboratory in Braga.

The press conference was opened to journalists and public, with invitation and resulted in a fruitful discussion between the public and the various speakers composed of researchers, clinicians, institutional from a cancer association and a politician from the Health Cluster Portugal

Read more


  • Prof. Lars Montelius, Director General of the International Iberian Nanotechnology Laboratory. “Welcome from INL’s DG”

  • Dr. Lorena Diéguez, Researcher in Biomedical Microfluidic Devices, International Iberian Nanotechnology Laboratory, ETPN representative. 

  • “Nanomedicine at INL and presentation of the European Technology Platform on Nanomedicine (ETPN)”

  • Patrícia Gomes, Portuguese Cancer Patients Association – Center of the Northern Region (Liga Portuguesa contra o Cancro – Núcleo Regional do Norte), Portugal. 

  • “Oncological experiences: the perspective of the psychologist”

  • Prof. Sonia Martínez Arca, Director of Innovation and Public Health Management, Galician Health Service, SERGAS, Spain. 

  • “inNANOvation in the Galician Public Health System”

  • Prof. Luis Costa, Oncologist, Professor of Medicine at the Lisbon Medical School–University of Lisbon, Director of the Oncology Division, Hospital de Santa Maria and head of the Clinical Translational Oncology Research Unit at IMM, Lisbon, Portugal.

  • “Nanomedicine in Cancer: what we can offer so far”

  • Dr. Juan Ruiz, Oncologist, Translational Medical Oncology; Health Research Institute of Santiago (IDIS), SERGAS, Spain. 

  • “The role of nanotechnology on the clinical practice of the oncologist physician”

  • Dr. Cristina Martins, Researcher in Biomaterials, I3S – Institute of Research and Innovation in Health, Portugal.

  • “Bioengineered biomaterials to fight Helicobacter pylori infection and prevent gastric cancer”

  • Prof. Nuno Miranda, National Coordinator of the Program in Oncological Diseases, General Administration of Public Health, Portugal.



7 press articles were issued in local and national newspapers: Diario Do Minho, Correio Do Minho, Press Minho, Antena Minho, OvilaverdenseJournal, Oamarense & International Iberian Nanotechnology Laboratory.


Organized by NanomedSpain the event took place at the University of Barcelona.

The press conference was opened to journalists and public. The event was covered by journalists from El Mundo, the first read national daily newspaper in Spain, and Gaceta Medica, a renowned clinician journal, and they wrote articles about the event.

Read more


  • Josep Samitier, Coordinator of NanomedSpain, Director of IBEC

  • Teresa López-Fando Salinas, Coordinator of Services and Programs, Spanish Association Against Cancer (AECC)

  • Mª Jesús Vicent, Research Group Leader at Principe Felipe research Centre (CIPF)

  • Mª Luisa Villahermosa, R+D Director at GENOMICA

  • Aleix Prat, Medical Oncologist and Research Group Leader at Oncological Institute at Vall d’Hebron Hospital (VHIO)


Great attendance with students, scientists and journalists asking interesting questions following the presentations.

Find the press articles about the event published in El Mundo and in Gaceta Medica.


Organized by University Hospital Zürich and the Ecole Polytechnique Fédérale de Lausanne, the event took place at Zürich, at University Hospital. The press conference was opened to journalists and public and gathered more than 50 people.

Read more


  • Prof. Dr. med. Roger STUPP, Clinic Director of Oncological Department, University Hospital Zürich
  • Prof. Dr. Heinrich HOFMANN, Director of the Powder Technology Laboratory, Institute of Materials, Ecole Polytechnique Fédérale de Lausanne
  • Prof. Dr. med. Beatrice BECK SCHIMMER, Leading Doctor at the Institute for Anaesthesiology from University Hospital Zürich
  • PD Dr. med. Dr. sc. hum. Dipl-Phys. Andreas BOSS, Leading Doctor at the Institute of Diagnostic and Interventional Radiology from University Hospital Zürich
  • Prof. Dr. med. Caroline MAAKE, Anatomical Institut, University Zürich
  • Prof. Dr. Niels KUSTER, Founder and Director of Foundation for Research on Information Technologies in Society (IT’IS)
  • Prof. Dr. med Niloy RANJAN DATTA, Senior Radio Oncologist, Kantonsspital Aarau
  • Prof. Gerrit BORCHARD, Pharmaceutical Sciences Department, Biopharmacy University of Geneva
  • Prof. em. Dr. phil. nat. Peter GEHR, Insitute of Anatomy, University of Bern


Find some materials regarding the Swiss event:

  • the Press Kit of the event with the BIO of the speakers and their presentation abstract here and there

The General Presentation Power Point in German here


Organized by the Gebze Technical University, the event took place at Gebze.

The event was a round table gathering 5 speakers, in front of a mixed audience composed of journalists, students, researchers and clinicians. This first edition in Turkey was covered with several interesting press articles issued in local and national newspaper.

Read more



Find a list of the articles issued, below:


Organized by Profiscio, the British Society for Nanomedicine, Endomag and Knowledge Transfer Network, the event took place at the University of Liverpool in London.

The press conference was opened to journalists and public and the exchanges were fruitful between the various speakers as entrepreneurs and researchers and the attendees.

Read more


  • Billy Boyle, Co-founder, Owlstone Medical

  • Dr Maya Thanou, Kings College London

  • Dr Eric Mayes, CEO, Endomag

  • Dr Christine Dufès, University of Strathclyde

  • Dr Kathryn Hill, AstraZeneca

  • Prof. Arwyn Tomos Jones, Membrane Traffic and Drug Delivery

  • Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University

  • Mr. Christopher Halloran, Consultant Pancreato-Biliary Surgeon

  • Institute of Translational Medicine, University of Liverpool

  • Prof. Andrew Owen, Chairman, British Society for Nanomedicine

  • Department of Molecular and Clinical Pharmacology, University of Liverpool

  • Dr Thanos Mitrelias, Founding CEO, Cavendish NanoTherapeutics

General material

Find the general material distributed to all the local participants: